Hecker M, Bayer M, Krombach G, Sommer N
Med Klin Intensivmed Notfmed. 2025; .
PMID: 40047895
DOI: 10.1007/s00063-025-01249-w.
Ghonem M, Abdelraouf I, Chua W
Cureus. 2025; 16(12):e76417.
PMID: 39872588
PMC: 11770163.
DOI: 10.7759/cureus.76417.
Risbano M, Risbano M
Ann Am Thorac Soc. 2025; 22(3):324-326.
PMID: 39835967
PMC: 11892657.
DOI: 10.1513/AnnalsATS.202412-1259ED.
Souza F, Ferreira M, Melo I, Sa M, Loureiro C, Abreu R
J Bras Pneumol. 2025; 50(6):e20240147.
PMID: 39813496
PMC: 11665283.
DOI: 10.36416/1806-3756/e20240147.
Heuts S, Kawczynski M, Leus A, Godinas L, Belge C, van Empel V
Eur Respir J. 2024; 65(2).
PMID: 39572220
PMC: 11865742.
DOI: 10.1183/13993003.01865-2024.
Analysis of riociguat and desmethyl riociguat by UPLC-MS/MS and its interaction with quercetin.
Li Q, Chen X, Zhang S, Li W, Lin H
Front Pharmacol. 2024; 15:1470377.
PMID: 39359248
PMC: 11444992.
DOI: 10.3389/fphar.2024.1470377.
Circulating Endothelin 1 but Not Transforming Growth Factor-β Levels Are Reduced after Pulmonary Endarterectomy in Subjects Affected by Chronic Thromboembolic Pulmonary Hypertension: A Prospective Cohort Study.
Totaro P, Tirelli C, De Amici M, Grosjean F, Testa G, Sacchi L
J Clin Med. 2024; 13(17).
PMID: 39274190
PMC: 11396395.
DOI: 10.3390/jcm13174977.
Chronic thromboembolic pulmonary disease.
Kim N, DArmini A, Delcroix M, Jais X, Jevnikar M, Madani M
Eur Respir J. 2024; 64(4).
PMID: 39209473
PMC: 11525345.
DOI: 10.1183/13993003.01294-2024.
Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies.
Staal D, Hendriks P, van Thor M, van de Groep L, van den Toorn L, Mulder B
Pulm Circ. 2024; 14(3):e12419.
PMID: 39175520
PMC: 11340011.
DOI: 10.1002/pul2.12419.
Peri-Operative Changes of Inflammatory Markers and Their Implications in Pulmonary Endarterectomy.
Liu Q, Zhao Z, Yang J, Cao Y, Zhang M
Rev Cardiovasc Med. 2024; 23(11):357.
PMID: 39076189
PMC: 11269080.
DOI: 10.31083/j.rcm2311357.
Programmed Follow-up and Quality Control of Treatment Techniques Enhance Chronic Thromboembolic Pulmonary Hypertension Management: Lessons From a Multidisciplinary Team.
Park T, Chang S, Yang J, Kwon W, Kim M, Cho Y
Korean Circ J. 2024; 54(7):409-421.
PMID: 38956937
PMC: 11252637.
DOI: 10.4070/kcj.2024.0021.
The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world study.
Zhang S, Li Y, Yang Y, Gong S, Yang Z, Hong C
BMC Pulm Med. 2024; 24(1):265.
PMID: 38825688
PMC: 11145764.
DOI: 10.1186/s12890-024-03042-5.
Insufficiency of quality of life as the treatment endpoint for balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension.
Gong J, Ding Y, Wang J, Wang W, Huang Q, Miao R
J Transl Int Med. 2024; 12(2):148-156.
PMID: 38779124
PMC: 11107180.
DOI: 10.2478/jtim-2022-0067.
The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia.
Krigere A, Kalejs V, Kaulins R, Rudzitis A, Bondare L, Sablinskis M
Medicina (Kaunas). 2024; 60(4).
PMID: 38674214
PMC: 11052274.
DOI: 10.3390/medicina60040568.
Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
Matsunaga T, Kono A, Nishio M, Yoshii T, Matsuo H, Takahashi M
PLoS One. 2024; 19(4):e0300716.
PMID: 38578764
PMC: 10997056.
DOI: 10.1371/journal.pone.0300716.
Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Insights from a Pilot Low-Volume Centre Study and a Comparative Analysis with Other Centres.
Ivanauskiene T, Cesna S, Grigoniene E, Gumbiene L, Daubaraite A, Ivanauskaite K
Medicina (Kaunas). 2024; 60(3).
PMID: 38541187
PMC: 10972510.
DOI: 10.3390/medicina60030461.
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with bronchial obstruction by a carcinoid tumor.
Monden Y, Une D, Mitsumune S, Shimokawahara H, Okada H, Yoshida K
Pulm Circ. 2024; 14(1):e12354.
PMID: 38486845
PMC: 10938258.
DOI: 10.1002/pul2.12354.
Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
Crowley A, Banfield M, Gupta A, Raj R, Gorantla V
Cureus. 2024; 16(1):e53336.
PMID: 38435894
PMC: 10907114.
DOI: 10.7759/cureus.53336.
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
Ongen H, Akdeniz B, Duzenli M, Chernyavsky A, Dabar G, Idrees M
Drugs Real World Outcomes. 2024; 11(1):149-165.
PMID: 38381283
PMC: 10928021.
DOI: 10.1007/s40801-023-00407-w.
Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients.
Kirkby L, Rodgers M, Amaral-Almeida L, Sheares K, Toshner M, Bunclark K
Pulm Circ. 2023; 13(3):e12265.
PMID: 37415805
PMC: 10320194.
DOI: 10.1002/pul2.12265.